# South Korea Avian Influenza Vaccine Market > South Korea Avian Influenza Vaccine Market Research Report By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Subunit Vaccines), By Administration Route (Intramuscular, Subcutaneous, Waterborne), By Target Species (Broilers, Layers, Breeders, Backyard Poultry) andBy Distribution Channel (Veterinary Clinics, Online Pharmacies, Retail Stores) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 2.05% - **2024:** $ 82.17 Million - **2025:** $ 83.85 Million - **2035:** $ 102.76 Million - **Key Players:** Boehringer Ingelheim (DE), Merck Animal Health (US), Zoetis (US), Elanco Animal Health (US), Ceva Santé Animale (FR), Heska Corporation (US), Vetoquinol (FR), Virbac (FR) **Report ID:** MRFR/Pharma/48045-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-avian-influenza-vaccine-market-49801 --- ## Market Summary ## **South Korea Avian Influenza Vaccine Market Overview** As per MRFR analysis, the South Korea Avian Influenza Vaccine Market Size was estimated at 79 (USD Million) in 2023. The South Korea Avian Influenza Vaccine Market Industry is expected to grow from 81 (USD Million) in 2024 to 156 (USD Million) by 2035. The South Korea Avian Influenza Vaccine Market CAGR (growth rate) is expected to be around 6.139% during the forecast period (2025 - 2035). ### **Key South Korea Avian Influenza Vaccine Market Trends Highlighted** Driven by the ongoing danger of avian influenza outbreaks, the South Korea Avian Influenza Vaccine Market is seeing an increasing emphasis on biosecurity practices in the poultry industry. To improve the monitoring of chicken farms, the South Korean government is progressively enforcing tighter rules, which thus calls for the creation and use of potent vaccinations. Especially given that chicken is a major component of South Korea's agricultural exports, key market drivers include the necessity for preserving food safety and safeguarding the poultry sector. Furthermore, the improvement of vaccination technology for example, the creation of more efficient and quick-response vaccines against many types of avian influenza would help to open possibilities in this sector. Partnerships between pharmaceutical corporations and research universities might provide creative answers for new viral types. Farmers' desire to avoid losses from disease outbreaks while following government rules will drive the need for successful immunization programs. Recent developments include a move toward more integrated disease management strategies, integrating vaccination with additional control measures like enhanced biosecurity policies and public awareness initiatives. The South Korean government is also giving more attention to funding veterinary public health projects, which supports a more robust chicken industry. Aiming to guarantee timely access to vaccinations, the inclusion of technology developments in vaccine manufacturing and distribution is also becoming more popular. Regulatory backing and the ongoing development of avian influenza threats will drive the general expansion of the South Korea Avian Influenza Vaccine Market, which is overall set to rise. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South Korea Avian Influenza Vaccine Market Drivers** ### **Increasing Incidence of Avian Influenza** The prevalence of avian influenza in South Korea has been a significant driver for the Avian Influenza Vaccine Market Industry. Following the outbreak of highly pathogenic avian influenza in 2021, the Ministry of Agriculture, Food and Rural Affairs reported that approximately 6 million birds were culled, which underscores the severity of the threat posed by this disease. This alarming statistic is driving poultry producers to seek vaccines more urgently than ever before to protect their livestock and stabilize the industry. The ongoing risk of avian influenza outbreaks necessitates a robust vaccination strategy, thereby propelling market growth in the country. Furthermore, initiatives by organizations such as the World Organisation for Animal Health (OIE) underscore the importance of vaccination as a preventative measure, thus enhancing the credibility and demand for avian influenza vaccines in South Korea. ### **Government Support and Policy Initiatives** Government support plays a crucial role in driving the South Korea Avian Influenza Vaccine Market Industry. The South Korean government has implemented various policy initiatives aimed at strengthening biosecurity measures, which includes financial assistance for vaccine access and distribution. The Korean Animal Health Association has advocated for increased funding to bolster Research and Development (R&D) in vaccine technologies, which is expected to enhance vaccine efficacy and uptake. Such policies demonstrate a commitment to improving poultry health, directly impacting the vaccination market. Reports indicate that government expenditure on animal health programs, which encompasses vaccine initiatives, has increased by approximately 15% over the last five years, showcasing the urgency and importance of addressing avian diseases. ### **Rising Poultry Consumption** The surge in poultry consumption in South Korea is a significant contributor to the expansion of the Avian Influenza Vaccine Market Industry. According to the South Korean Ministry of Agriculture, Food and Rural Affairs, the average poultry consumption per capita has increased steadily, reaching about 30 kilograms per person annually in recent years. This rise in consumption is driven by changing dietary preferences amongst the Korean population, as poultry is a staple protein source. In tandem with increased demand, there is a growing focus on ensuring livestock health and safety, further amplifying the need for effective vaccination programs. The heightened consumption signifies that the poultry industry must maintain robust health standards, making vaccinations imperative in mitigating disease outbreaks. ## **South Korea Avian Influenza Vaccine Market Segment Insights** ### **Avian Influenza Vaccine Market Vaccine Type Insights** The South Korea Avian Influenza Vaccine Market encompasses various vaccine types that play critical roles in disease prevention and management in poultry. Among these, Live Attenuated Vaccines are particularly noted for their ability to induce a strong immune response, making them a preferred choice in various vaccination programs. These vaccines allow for broader immunological coverage, which is vital, especially in high-density poultry farming regions in South Korea. Inactivated Vaccines, on the other hand, have gained prominence due to their safety profile and reliability. They are especially favored in scenarios where live vaccines could evoke concerns regarding reversion to virulence. As the country is a major hub for poultry production, the demand for these inactivated formulations is significant, aligning with the industry’s need for sustainable health management practices. Recombinant Vaccines represent an innovative approach within the South Korea Avian Influenza Vaccine Market, utilizing genetic engineering techniques to enhance efficacy while maintaining safety. These vaccines have the potential to rapidly adapt to emerging strains of the virus, making them a timely solution in the face of evolving pathogens. This adaptability is vital in countries like South Korea, where the poultry industry is susceptible to outbreaks of avian influenza. Lastly, Subunit Vaccines are increasingly recognized for their ability to trigger a targeted immune response without the use of live pathogens. This makes them an attractive option in biosecurity-focused environments, thereby contributing to a secure poultry sector. The South Korea Avian Influenza Vaccine Market data reflects a strategical transition towards vaccines that promote better biosecurity measures, indicating a growth trajectory influenced by both advancements in veterinary medicine and increased awareness of disease management among poultry farmers. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Avian Influenza Vaccine Market Administration Route Insights** The South Korea Avian Influenza Vaccine Market showcases diversified Administration Routes essential for effective immunization strategies. Among these, Intramuscular and Subcutaneous routes are widely used in veterinary practices, given their efficiency in delivering vaccines directly into muscle tissue or just beneath the skin. This direct administration efficiently mobilizes immune responses, thereby ensuring quicker protection for avian species against avian influenza. The Waterborne route also plays a significant role by allowing mass vaccinations through the animals' drinking water, which is particularly advantageous in poultry farming due to its convenience and low stress on birds during administration. Each method has its own advantages and is strategically utilized based on the specific needs of different avian populations. The ongoing growth of the South Korea Avian Influenza Vaccine Market is driven by an increase in poultry farming and the need for biosecurity measures, highlighting the importance of these Administration Routes in safeguarding poultry against influenza outbreaks. Overall, the segmentation in this market reflects the demand for effective and accessible vaccination methods to combat avian diseases. ### **Avian Influenza Vaccine Market Target Species Insights** The South Korea Avian Influenza Vaccine Market, focusing on Target Species, reveals significant trends and opportunities across various categories such as Broilers, Layers, Breeders, and Backyard Poultry. Broilers and Layers comprise a substantial portion of avian production in South Korea, thus necessitating comprehensive vaccination strategies to prevent outbreaks that could affect poultry health and production efficiency. Breeders are essential as they are responsible for the genetic stock necessary for both Broilers and Layers, emphasizing the need for their protection against avian influenza to ensure a sustainable poultry industry. Meanwhile, the Backyard Poultry segment continues to grow in importance, often representing a key source of livelihood for many rural households. This segment’s vulnerability to avian diseases highlights the necessity of effective vaccination strategies to protect local farmers and their incomes. With heightened awareness and regulatory support for biosecurity measures, the focus on vaccines for these Target Species is expected to enhance the overall resilience of the poultry industry in South Korea, leading to improved public health outcomes and economic stability. ### **Avian Influenza Vaccine Market Distribution Channel Insights** In the South Korea Avian Influenza Vaccine Market, the Distribution Channel segment plays a crucial role in ensuring effective vaccine accessibility and delivery. Veterinary Clinics are significant distribution points, as they provide specialized care and guidance to poultry farmers, thereby fostering trust and consistent usage of vaccines among livestock producers. Meanwhile, Online Pharmacies have emerged as an increasingly popular channel due to their convenience and the growing trend of digital health services within South Korea, making vaccines easy to obtain without geographical limitations. Retail Stores also facilitate the distribution of avian influenza vaccines, catering to local farmers and individuals with immediate needs, thereby enhancing vaccine availability in rural areas. The synergy among these channels not only streamlines the supply chain but also aligns with South Korea's focus on biosecurity and public health. Overall, the effective interplay of these distribution channels is essential for maintaining robust vaccine coverage, addressing outbreaks promptly, and ensuring the safety of poultry populations, which is vital to the agriculture sector in South Korea. As the market evolves, these channels are expected to adapt to consumer behavior shifts, presenting opportunities for innovative distribution strategies. ## **South Korea Avian Influenza Vaccine Market Key Players and Competitive Insights** The South Korea Avian Influenza Vaccine Market is characterized by its dynamic landscape, shaped by a need for innovative solutions to combat avian influenza outbreaks among poultry populations. This market has seen significant consolidation and exploration of partnerships among manufacturers, as stakeholders strive to enhance their product offerings and expand their market reach. The increasing concerns over biosecurity, coupled with stricter regulatory frameworks, have motivated companies to invest heavily in research and development. Consequently, the competitive environment is influenced by both local players and international firms that seek to capitalize on the growing demand for effective vaccination solutions against avian influenza. Merial has established a prominent presence in the South Korean Avian Influenza Vaccine Market, recognized for its advanced vaccine formulations tailored to the needs of poultry producers in the region. The company's strength lies in its consistent investment in research, enabling it to provide high-quality products that meet the rigorous approval standards set by local authorities. Merial's dedication to biosecurity solutions has positioned it as a trusted partner for poultry farmers, contributing significantly to disease control efforts in South Korea. The company's reputation for reliability and efficacy in its vaccine offerings further solidifies its competitive stance in the market. Vaxxinova, another key player in the South Korean Avian Influenza Vaccine Market, specializes in developing innovative vaccines that are crucial for the health and productivity of poultry. The company boasts a diverse portfolio of avian vaccines and has made significant investments in collaborative research projects to enhance its product range. Vaxxinova's strengths include its ability to leverage advanced technologies and its strong distribution network, ensuring its products are accessible to poultry producers across South Korea. Notably, Vaxxinova has pursued strategic mergers and acquisitions to expand its technological capabilities and market presence. These initiatives have been instrumental in reinforcing the company's foothold in the competitive landscape, allowing it to respond effectively to the evolving needs of the market while maintaining a focus on quality and customer satisfaction. ### **Key Companies in the South Korea Avian Influenza Vaccine Market Include** ## **South Korea Avian Influenza Vaccine Market Industry Developments** Amid ongoing concerns regarding avian influenza outbreaks in South Korea, the domestic market for avian influenza vaccines has been gaining traction, leading to increased investments and development efforts. Recently, Merial and Boehringer Ingelheim have expanded their vaccine R&D initiatives within the region, focusing on enhancing efficacy against emerging viral strains. Additionally, companies like Zoetis and Hester Biosciences are reportedly scaling up production capacities to meet the rising demand from poultry farmers, particularly following significant outbreaks reported in late 2022. In terms of mergers and acquisitions, reports emerged in July 2023 that Vaxxinova has acquired a local biotechnology firm, enhancing its distribution capabilities in South Korea. The market is projected to experience a robust growth rate driven by heightened biosecurity measures and government initiatives aimed at controlling avian influenza. The South Korean government has also been proactive in subsidizing vaccination programs for poultry to mitigate economic losses caused by avian flu, underscoring the importance of this segment in national health and agriculture policies. With universities such as the University of Queensland collaborating on vaccine research, the synergistic efforts among various industry stakeholders are expected to bolster the overall market landscape in the coming years. ## **South Korea Avian Influenza Vaccine Market Segmentation Insights** ### **Avian Influenza Vaccine Market Vaccine Type Outlook** ### **Avian Influenza Vaccine Market Administration Route Outlook** ### **Avian Influenza Vaccine Market Target Species Outlook** ### **Avian Influenza Vaccine Market Distribution Channel Outlook** ## Market Drivers ### Public Health Initiatives Public health initiatives aimed at controlling avian influenza outbreaks are significantly impacting the avian influenza-vaccine market. The South Korean government has launched various campaigns to educate farmers and the general public about the importance of vaccination in preventing disease spread. These initiatives are likely to increase vaccination rates among poultry, thereby reducing the risk of outbreaks. The government allocates substantial funding for these programs, which is expected to enhance the market's growth trajectory. As awareness of avian influenza's potential impact on public health rises, the demand for vaccines is anticipated to grow, further solidifying the avian influenza-vaccine market's position in the agricultural sector. ### Increased Poultry Production The avian influenza-vaccine market is significantly influenced by the rising demand for poultry products in South Korea. As the population grows and dietary preferences shift towards protein-rich foods, poultry production is expected to increase. This surge in production heightens the risk of avian influenza outbreaks, necessitating the widespread use of vaccines to protect flocks. The market is anticipated to witness a growth rate of around 7% annually, driven by the need for biosecurity measures in poultry farms. Farmers are increasingly recognizing the importance of vaccination as a preventive strategy, thereby propelling the avian influenza-vaccine market forward. The economic implications of poultry farming further underscore the necessity for effective vaccination programs. ### Emerging Research and Development Innovations in vaccine technology are playing a pivotal role in shaping the avian influenza-vaccine market. Research institutions and pharmaceutical companies in South Korea are actively engaged in developing next-generation vaccines that offer improved efficacy and safety profiles. The focus on recombinant vaccines and adjuvants is expected to enhance immune responses in poultry, thereby reducing the incidence of avian influenza. Investment in R&D is projected to increase by approximately 15% over the next few years, reflecting the commitment to advancing vaccine technology. This emphasis on innovation not only addresses current challenges but also positions the avian influenza-vaccine market for future growth, ensuring that South Korea remains at the forefront of vaccine development. ### International Trade Opportunities The avian influenza-vaccine market is poised to benefit from international trade opportunities as South Korea strengthens its position in The avian influenza-vaccine market. With the increasing demand for poultry products worldwide, South Korean vaccine manufacturers are exploring export possibilities. The government is actively promoting trade agreements that facilitate the export of vaccines, which could lead to a market expansion of approximately 10% in the coming years. By adhering to international quality standards, South Korean companies can enhance their competitiveness in the global arena. This potential for international trade not only boosts the avian influenza-vaccine market but also contributes to the overall economic growth of the country. ### Regulatory Framework Enhancements The avian influenza-vaccine market in South Korea is experiencing a boost due to the strengthening of regulatory frameworks. The government has implemented stringent guidelines to ensure the safety and efficacy of vaccines. This regulatory environment fosters innovation and encourages pharmaceutical companies to invest in research and development. As a result, the market is projected to grow at a CAGR of approximately 8% over the next five years. Enhanced regulations not only protect public health but also instill confidence among consumers and stakeholders in the avian influenza-vaccine market. Furthermore, compliance with international standards may facilitate export opportunities for South Korean vaccine manufacturers, thereby expanding their market reach. ## Future Outlook The [Avian Influenza Vaccine Market](https://www.marketresearchfuture.com/reports/avian-influenza-vaccine-market-8769) is projected to grow at a 2.05% CAGR from 2025 to 2035, driven by increasing poultry production and enhanced biosecurity measures. **New opportunities:** - Development of customized vaccine formulations for regional poultry breeds. - Investment in advanced cold chain logistics for vaccine distribution. - Partnerships with local farms for on-site vaccination programs. By 2035, the market is expected to achieve robust growth, driven by strategic innovations and partnerships. ## Segment Insights ### By Type: Live Attenuated Vaccines (Largest) vs. Inactivated Vaccines (Fastest-Growing) In the South Korea avian influenza-vaccine market, the distribution of market share among different vaccine types shows that live attenuated vaccines hold the largest share due to their efficacy and cost-effectiveness in preventing outbreaks. In contrast, inactivated vaccines are increasingly gaining traction, driven by heightened awareness of biosecurity and the need for safer vaccine options. These dynamics reflect a balanced preference for traditional approaches while also accommodating innovations in vaccine development. The growth trends in this segment are markedly influenced by factors such as advancements in vaccine formulation technologies and the rising demand for poultry health management due to the persistent threat of avian influenza. The inactivated vaccines segment is projected to experience the fastest growth as more producers opt for these products for their safety and reliability. Additionally, increased government support for vaccination programs further stimulates market expansion, promoting healthier livestock and overall poultry productivity. Live Attenuated Vaccines (Dominant) vs. Recombinant Vaccines (Emerging) Live attenuated vaccines are considered the dominant force in the South Korea avian influenza-vaccine market due to their proven effectiveness and ability to elicit a robust immune response. They are commonly used in poultry populations to prevent outbreaks and are favored by many producers for their cost efficiency. Conversely, recombinant vaccines represent an emerging category, leveraging advanced biotechnology to improve safety and efficacy. These vaccines are engineered to provide targeted protection against specific avian influenza strains, thereby offering innovative solutions to evolving viral threats. As the market evolves, both types may play pivotal roles in ensuring disease control and enhancing poultry production resilience. ### By Administration Route: Intramuscular (Largest) vs. Waterborne (Fastest-Growing) The South Korea avian influenza-vaccine market is witnessing a varied distribution among its administration routes. Intramuscular injection remains the largest segment, commanding a significant portion of the market share, as it is widely accepted for its effectiveness. In contrast, the subcutaneous and waterborne methods occupy smaller shares, but have their unique applications that cater to specific use cases in poultry vaccination. Growth trends indicate a positive trajectory for the entire segment, but waterborne administration is emerging as the fastest-growing route due to its ease of use and lower stress on birds during vaccination. Increasing awareness of avian influenza among poultry farmers, along with government initiatives for vaccination drives, are key drivers that bolster the adoption of diverse administration methods. Intramuscular (Dominant) vs. Waterborne (Emerging) Intramuscular administration is the dominant method in the South Korea avian influenza-vaccine market, primarily due to its direct delivery and quick response in immunizing birds. It is often preferred for its reliability in eliciting an immediate immune response. On the other hand, waterborne vaccination is becoming an emerging method, gaining traction particularly for its convenience and user-friendliness. Farmers appreciate the ability to vaccinate flocks during routine watering, which minimizes labor and stress on birds. Both methods play essential roles in controlling disease outbreaks, with intramuscular being the conventional choice and waterborne offering innovative advantages as the market evolves. ### By Target Species: Broilers (Largest) vs. Layers (Fastest-Growing) In the South Korea avian influenza-vaccine market, the distribution of market share among target species reveals that broilers hold the largest proportion, driven by their high demand in the poultry industry. Layers follow, experiencing significant interest due to growing concerns over avian influenza outbreaks and their impact on egg production. Backyard poultry and breeders constitute smaller yet crucial segments that reflect niche markets focused on sustainable practices and local food production. Growth trends indicate a robust future for broilers as vaccination protocols improve and awareness of health measures expands. Layers are emerging as the fastest-growing segment, spurred by increasing consumer demand for safe and healthy eggs. The backyard poultry sector is also witnessing a rise due to shifting consumer preferences towards home-grazed and organic poultry products, highlighting the importance of vaccination in maintaining poultry health. Broilers: Dominant vs. Layers: Emerging Broilers are recognized as the dominant segment in the South Korea avian influenza-vaccine market due to their pivotal role in poultry meat production. The large-scale operations and centralized production methods allow for streamlined vaccination processes, enhancing biosecurity measures against avian influenza. In contrast, layers present an emerging segment, gaining traction as consumers increasingly prioritize egg safety and quality, prompted by rising food safety standards. The growth of backyard poultry further complements this shift, as local farmers seek effective vaccination solutions to sustain small-scale poultry health and productivity. ### By Distribution Channel: Veterinary Clinics (Largest) vs. Online Pharmacies (Fastest-Growing) In the South Korea avian influenza-vaccine market, Veterinary Clinics hold the largest market share, providing essential services for vaccination and health management of poultry. Their established relationships with farmers and direct access to livestock ensure a stable demand for vaccines. Online Pharmacies, meanwhile, are rapidly gaining traction, catering to the tech-savvy population and offering convenient access to avian vaccines. This shift towards online purchasing is reshaping traditional distribution dynamics. The growth trends in this segment are primarily driven by increasing adoption of vaccination practices among poultry farmers and rising awareness about avian influenza risks. Furthermore, the pandemic has accelerated the shift to online purchasing, with Online Pharmacies emerging as a preferred option for many. The convenience, availability of information, and competitive pricing within this channel contribute to its fastest growth trajectory in the market. Veterinary Clinics (Dominant) vs. Online Pharmacies (Emerging) Veterinary Clinics are a dominant force in the South Korea avian influenza-vaccine market, characterized by their trusted reputation and direct engagement with poultry farmers. They not only provide vaccines but also offer comprehensive veterinary care, ensuring healthy livestock production. The convenience and expertise offered by these clinics solidify their position in the market. On the other hand, Online Pharmacies represent an emerging channel that is capturing the attention of consumers due to their convenience and accessibility. These platforms are increasingly popular among farmers who prefer ordering vaccines online, allowing for quick replenishment and broader access to different products. With the growing trend of digitalization in the agricultural sector, Online Pharmacies are becoming a key player in enhancing vaccine distribution. ## Competitive Benchmarking The avian influenza-vaccine market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and regional expansion. Key players such as Boehringer Ingelheim (DE), Merck Animal Health (US), and Zoetis (US) are at the forefront, each employing distinct strategies to enhance their market presence. Boehringer Ingelheim (DE) focuses on research and development, aiming to introduce next-generation vaccines that address emerging strains of avian influenza. Meanwhile, Merck Animal Health (US) emphasizes strategic collaborations with local poultry producers to ensure tailored solutions that meet specific regional needs. Zoetis (US) appears to be leveraging its extensive distribution network to enhance accessibility and affordability of its vaccine products, thereby solidifying its competitive edge.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies remains pronounced. This dynamic fosters a competitive environment where innovation and operational efficiency are paramount, as companies strive to differentiate themselves in a crowded marketplace. In October Boehringer Ingelheim (DE) announced a partnership with a leading South Korean agricultural university to develop a novel vaccine platform aimed at enhancing the efficacy of avian influenza vaccines. This collaboration is strategically significant as it not only bolsters Boehringer's R&D capabilities but also aligns with the growing emphasis on academic partnerships to drive innovation in veterinary medicine. In September Merck Animal Health (US) launched a new marketing campaign targeting poultry farmers, highlighting the importance of vaccination in preventing avian influenza outbreaks. This initiative underscores Merck's commitment to education and awareness, which is crucial in a market where farmers may be hesitant to adopt new vaccination protocols. By positioning itself as a thought leader, Merck aims to strengthen its brand loyalty among poultry producers. In August Zoetis (US) expanded its production facility in South Korea, increasing its capacity to manufacture avian influenza vaccines. This expansion is indicative of Zoetis's long-term commitment to the region and its recognition of the growing demand for effective vaccination solutions. By enhancing its production capabilities, Zoetis is likely to improve its supply chain reliability, which is increasingly critical in a market where timely access to vaccines can significantly impact poultry health outcomes. As of November the competitive trends in the avian influenza-vaccine market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence in vaccine development and distribution. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in navigating complex regulatory environments and enhancing product offerings. Looking ahead, competitive differentiation is expected to evolve from traditional price-based strategies to a focus on innovation, technological advancements, and robust supply chain management, reflecting a broader shift in the industry towards sustainable and reliable solutions. ## Recent News & Developments Amid ongoing concerns regarding avian influenza outbreaks in South Korea, the domestic market for avian influenza vaccines has been gaining traction, leading to increased investments and development efforts. Recently, Merial and Boehringer Ingelheim have expanded their vaccine R&D initiatives within the region, focusing on enhancing efficacy against emerging viral strains. Additionally, companies like Zoetis and Hester Biosciences are reportedly scaling up production capacities to meet the rising demand from poultry farmers, particularly following significant outbreaks reported in late 2022. In terms of mergers and acquisitions, reports emerged in July 2023 that Vaxxinova has acquired a local biotechnology firm, enhancing its distribution capabilities in South Korea. The market is projected to experience a robust growth rate driven by heightened biosecurity measures and government initiatives aimed at controlling avian influenza. The South Korean government has also been proactive in subsidizing vaccination programs for poultry to mitigate economic losses caused by avian flu, underscoring the importance of this segment in national health and agriculture policies. With universities such as the University of Queensland collaborating on vaccine research, the synergistic efforts among various industry stakeholders are expected to bolster the overall market landscape in the coming years. ## Report Scope | MARKET SIZE 2024 | 82.17(USD Million) | | --- | --- | | MARKET SIZE 2025 | 83.85(USD Million) | | MARKET SIZE 2035 | 102.76(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 2.05% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Boehringer Ingelheim (DE), Merck Animal Health (US), Zoetis (US), Elanco Animal Health (US), Ceva Santé Animale (FR), Heska Corporation (US), Vetoquinol (FR), Virbac (FR) | | Segments Covered | Type, Administration Route, Target Species, Distribution Channel | | Key Market Opportunities | Emerging biotechnologies enhance vaccine efficacy and production speed in the avian influenza-vaccine market. | | Key Market Dynamics | Rising demand for avian influenza vaccines driven by regulatory changes and heightened biosecurity measures in poultry farming. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What was the overall market valuation of the avian influenza-vaccine market in 2024?** A: The overall market valuation was $82.17 Million in 2024. **Q: What is the projected market valuation for the avian influenza-vaccine market by 2035?** A: The projected valuation for 2035 is $102.76 Million. **Q: What is the expected CAGR for the avian influenza-vaccine market during the forecast period 2025 - 2035?** A: The expected CAGR during the forecast period 2025 - 2035 is 2.05%. **Q: Which companies are considered key players in the avian influenza-vaccine market?** A: Key players include Boehringer Ingelheim, Merck Animal Health, Zoetis, Elanco Animal Health, Ceva Santé Animale, Heska Corporation, Vetoquinol, and Virbac. **Q: What are the different types of vaccines available in the avian influenza-vaccine market?** A: Types of vaccines include Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Subunit Vaccines. **Q: What was the market value of Inactivated Vaccines in 2024?** A: The market value of Inactivated Vaccines was $30.0 Million in 2024. **Q: How is the avian influenza-vaccine market segmented by administration route?** A: The market is segmented into Intramuscular, Subcutaneous, and Waterborne administration routes. **Q: What is the market value for Broilers in the avian influenza-vaccine market?** A: The market value for Broilers was $30.0 Million in 2024. **Q: Which distribution channels are utilized in the avian influenza-vaccine market?** A: Distribution channels include Veterinary Clinics, Online Pharmacies, and Retail Stores. **Q: What was the market value for Veterinary Clinics in 2024?** A: The market value for Veterinary Clinics was $30.0 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-avian-influenza-vaccine-market-49801*